9966.HK
9966.HK
KYG0330A1013
ALPHAMAB-B
Loading chart...

Company Profile

-

Related stocks

9887.HK
9887.HK • China
LEADS BIOLABS-B
45.56 HKD
1.15B USD 1Y -37.5%
688366.SS
688366.SS • China
SHANGHAI HAOHAI BIOLOGICAL TECH
30.77 CNY
1.03B USD 1Y -41%
000990.SZ
000990.SZ • China
CHENGZHI
6.41 CNY
1.17B USD 1Y +22.1%
688526.SS
688526.SS • China
WUHAN KEQIAN BIOLOGY CO LTD
12.41 CNY
865.58M USD 1Y -29.4%
2171.HK
2171.HK • China
CARSGEN-B
11.63 HKD
844.52M USD 1Y -39.7%
1952.HK
1952.HK • China
EVEREST MED
29.6 HKD
1.33B USD 1Y -47.1%
300841.SZ
300841.SZ • China
KANGHUA BIOLOGICAL
55.26 CNY
1.07B USD 1Y -28.5%
2595.HK
2595.HK • China
GENFLEET-B
28.6 HKD
1.4B USD 1Y -21%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
82.0% p.a.
Max Drawdown (5Y)
-89.4%
Sharpe Ratio (5Y)
-0.23
Beta Factor
0.55
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Elevated Short-Term Volatility: 3Y volatility (86.7%) is noticeably higher than the 5Y average (82.0%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (82.0% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -89.4% in the extended horizon.
ende